Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects

MOTOHISA YAMAMOTO, KEN-ICHI TAKANO and HIROKI TAKAHASHI
The Journal of Rheumatology September 2018, 45 (9) 1339-1340; DOI: https://doi.org/10.3899/jrheum.180163
MOTOHISA YAMAMOTO
Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mocha@cocoa.plala.or.jp
KEN-ICHI TAKANO
Department of Otolaryngology, Sapporo Medical University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKI TAKAHASHI
Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan. This work was supported by the Research on Measures for Intractable Diseases Project matching fund subsidy from the Ministry of Health, Labor, and Welfare, Japan, and the Japan Agency for Medical Research and Development.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 45 no. 9 1339-1340
DOI 
https://doi.org/10.3899/jrheum.180163
PubMed 
30173184

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online September 1, 2018.

Copyright & Usage 
© 2018

Author Information

  1. MOTOHISA YAMAMOTO, MD, PhD⇑
  1. Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine;
  1. Address correspondence to Dr. M. Yamamoto, Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1 West 16, Chuo-ku, Sapporo, Hokkaido 0608543, Japan. E-mail: mocha{at}cocoa.plala.or.jp
  1. KEN-ICHI TAKANO, MD, PhD
  1. Department of Otolaryngology, Sapporo Medical University School of Medicine;
  1. HIROKI TAKAHASHI, MD, PhD
  1. Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan. This work was supported by the Research on Measures for Intractable Diseases Project matching fund subsidy from the Ministry of Health, Labor, and Welfare, Japan, and the Japan Agency for Medical Research and Development.

Article usage

Article usage: August 2018 to February 2023

AbstractFullPdf
Aug 2018430
Sep 201828817453
Oct 2018514918
Nov 2018423910
Dec 20188300
Jan 201914378
Feb 201913295
Mar 2019133117
Apr 20191074
May 20197135
Jun 20194132
Jul 2019113610
Aug 201914246
Sep 20192175
Oct 201912225
Nov 201962712
Dec 20190203
Jan 202021810
Feb 20200202
Mar 20203173
Apr 202002611
May 2020183
Jun 20203154
Jul 2020484
Aug 20204187
Sep 20205134
Oct 20202222
Nov 2020482
Dec 20209121
Jan 2021485
Feb 20211133
Mar 20214125
Apr 202122010
May 202112311
Jun 20210441
Jul 20213306
Aug 202121110
Sep 20211168
Oct 20213617
Nov 202111617
Dec 20210544
Jan 20222301
Feb 20221532
Mar 2022175
Apr 20221109
May 2022336
Jun 2022257
Jul 2022161
Aug 20220253
Sep 20223118
Oct 2022444
Nov 2022345
Dec 2022134
Jan 20231128
Feb 2023063

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 45, Issue 9
1 Sep 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects
MOTOHISA YAMAMOTO, KEN-ICHI TAKANO, HIROKI TAKAHASHI
The Journal of Rheumatology Sep 2018, 45 (9) 1339-1340; DOI: 10.3899/jrheum.180163

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects
MOTOHISA YAMAMOTO, KEN-ICHI TAKANO, HIROKI TAKAHASHI
The Journal of Rheumatology Sep 2018, 45 (9) 1339-1340; DOI: 10.3899/jrheum.180163
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • COVID-19 Vaccination as a Trigger of IgA Vasculitis: Truth or Illusion?
  • Drs. Ramdani and Audemard-Verger reply
  • Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire
Show more Letters

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire